Pharmaceutical

Phebra, University of Wollongong partner to develop cancer therapies

Pharmaceutical firm Phebra has reached a new six-year collaboration agreement with Australia’s University of Wollongong (UOW)

Aug 28, 2023 - 20:00
Phebra, University of Wollongong partner to develop cancer therapies
Pharmaceutical firm Phebra has reached a new six-year collaboration agreement with Australia’s University of Wollongong (UOW)
Read the original article

Tags:

Previous Article

Specialised Therapeutics partners with Treeway to license ALS drug

Next Article

Sandoz concludes acquisition of Mycamine antifungal agent from Astellas

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

First pediatric study to test neutralizing antibodies against HIV shows promise

First pediatric study to test neutralizing antibodies a...

Jul 6, 2023

RareStone’s narcolepsy therapy receives approval in China

RareStone’s narcolepsy therapy receives approval in China

Jul 5, 2023

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity

Bicara Therapeutics closes $362m IPO in flurry of biote...

Sep 18, 2024